Future Therapy for HBV: Role of Immunomodulators
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Future Therapy for HBV: Role of Immunomodulators

Current Hepatology Reports

Edward A. Pham, Ryan B. Perumpail, Benjamin J. Fram, Jeffrey S. Glenn, Aijaz Ahmed & Robert G. Gish

Abstract: Although currently available therapies for chronic hepatitis B virus infection can suppress viremia and provide long-term benefits for patients, they do not lead to a functional cure for most patients. Advances in our understanding of the virus-host interaction and the recent remarkable success of immunotherapy in cancer offer new and promising strategies for developing immune modulators that may become important components of a total therapeutic approach to hepatitis B, some of which are now in clinical development.

» Open/Download Article


Metadata